16 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp05376 | peptide containing the BH3 regions from Bid | RNIARHLAQVGDSMDR | BH3-only, Direct activators (PUMA, Bid) | Inducing apoptosis | Agarose gel electrophoresis assay | Not found | Not specified | Not found |
| dbacp05760 | PUMA BH3 | EQWAREIGAQLRRMADDLNA | BH3-only, Direct activators (PUMA, Bid) | Inducing apoptosis | Not specified | Not found | Not specified | Not found |
| dbacp05761 | PUMA BH3 | LRRMADDLN | BH3-only, Direct activators (PUMA, Bid) | Inducing apoptosis | Not specified | MDA-MB-231 | Colon cancer | Not found |
| dbacp05762 | PUMA BH4 | LRRMADDLN | BH3-only, Direct activators (PUMA, Bid) | Inducing apoptosis | Not specified | HCT116p53–/– | Colon cancer | Not found |
| dbacp05763 | PUMA BH5 | LRRMADDLN | BH3-only, Direct activators (PUMA, Bid) | Inducing apoptosis | Not specified | HCT116p53+/+ | Colon cancer | Not found |
| dbacp05764 | PUMA BH6 | LRRMADDLN | BH3-only, Direct activators (PUMA, Bid) | Inducing apoptosis | Not specified | GLC-82 | Colon cancer | Not found |
| dbacp05765 | PUMA BH7 | LRRMADDLN | BH3-only, Direct activators (PUMA, Bid) | Inducing apoptosis | Not specified | SGC-7901 | Colon cancer | Not found |
| dbacp05766 | PUMA BH8 | LRRMADDLN | BH3-only, Direct activators (PUMA, Bid) | Inducing apoptosis | Not specified | HEK293 | Colon cancer | Not found |
| dbacp05767 | PUMA BH9 | LRRMADDLN | BH3-only, Direct activators (PUMA, Bid) | Inducing apoptosis | Not specified | 2BS | Colon cancer | Not found |
| dbacp06208 | TAT-DV3-BH3 | YGRKKRRQRRRGGGLGASWHRPDKGGGGLRRMADDLNAQY | BH3-only, Direct activators (PUMA, Bid) | Inducing apoptosis | CCK-8 assay | HCT116p53–/– | Colon cancer | Survival rate : 32.19 ± 6.42% |
| dbacp06209 | TAT-DV3-BH3 | YGRKKRRQRRRGGGLGASWHRPDKGGGGLRRMADDLNAQY | BH3-only, Direct activators (PUMA, Bid) | Inducing apoptosis | CCK-8 assay | HCT116p53+/+ | Colon cancer | Survival rate : 34.28 ± 8.93% |
| dbacp06210 | TAT-DV3-BH3 | YGRKKRRQRRRGGGLGASWHRPDKGGGGLRRMADDLNAQY | BH3-only, Direct activators (PUMA, Bid) | Inducing apoptosis | CCK-8 assay | GLC-82 | Colon cancer | Survival rate : 63.64 ± 4.80% |
| dbacp06211 | TAT-DV3-BH3 | YGRKKRRQRRRGGGLGASWHRPDKGGGGLRRMADDLNAQY | BH3-only, Direct activators (PUMA, Bid) | Inducing apoptosis | CCK-8 assay | SGC-7901 | Colon cancer | Survival rate : 64.75 ± 33.48% |
| dbacp06212 | TAT-DV3-BH3 | YGRKKRRQRRRGGGLGASWHRPDKGGGGLRRMADDLNAQY | BH3-only, Direct activators (PUMA, Bid) | Inducing apoptosis | CCK-8 assay | MDA-MB-231 | Colon cancer | Survival rate : 69.79 ± 6.71% |
| dbacp06213 | TAT-DV3-BH3 | YGRKKRRQRRRGGGLGASWHRPDKGGGGLRRMADDLNAQY | BH3-only, Direct activators (PUMA, Bid) | Inducing apoptosis | CCK-8 assay | HEK293 | Colon cancer | Survival rate : 115.85 ± 23.03% |
| dbacp06214 | TAT-DV3-BH3 | YGRKKRRQRRRGGGLGASWHRPDKGGGGLRRMADDLNAQY | BH3-only, Direct activators (PUMA, Bid) | Inducing apoptosis | CCK-8 assay | 2BS | Colon cancer | Survival rate : 124.38 ± 22.05% |